Tag: AVG
“Very encouraging” 12-month data from WRAPSODY FIRST study presented at CIRSE...
Twelve-month results from a first-in-human study of the Wrapsody cell-impermeable endoprosthesis (Merit Medical Systems) for the treatment of access circuit stenosis in haemodialysis patients...
First data from AVeVA suggest Covera stent “safe and effective” at...
Early data from the prospective multicentre AVeVA study that employed a covered stent (Covera; Bard, now BD) to treat stenoses at the venous anastomosis...
Latest data on Lutonix and IN.PACT drug-coated balloons in AV access...
There in an increasing physician interest in exploring the role of drug-coated balloons in arteriovenous (AV) access. At the Leipzig Interventional Course (LINC; 30...